Cancer Center Amsterdam
-
Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study
Dieckman, T., Schumann, M., Beaumont, H., Bontkes, H. J., Koning, F., Bouma, G., Byrnes, V., McCarthy, J., Neefjes-Borst, A., Loddenkemper, C., van Bergen, J., Weegh, M. O. D. & RCDII Tofacitinib Consortium, 2024, (E-pub ahead of print) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Short survey › Academic › peer-review
-
Severe multiple therapy refractory colitis in a 46-year-old man
Carpay, N., de Boer, N. K. H., Neefjes-Borst, A. & Bots, S., 2024, (E-pub ahead of print) In: Gut. gutjnl-2024-331934.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Viscoelastic properties of small bowel mesentery at MR elastography in Crohn’s disease: a prospective cross-sectional exploratory study
van Schelt, A-S., Beek, K. J., Wassenaar, N. P. M., Schrauben, E. M., Runge, J. H., Gecse, K. B., van der Bilt, J. D. W., Neefjes-Borst, E. A., Buskens, C. J., Nederveen, A. J. & Stoker, J., 1 Dec 2023, In: European Radiology Experimental. 7, 1, 53.Research output: Contribution to journal › Article › Academic › peer-review
- All publications